Basilea Pharmaceutica AG (LON: 0QNA)
London
· Delayed Price · Currency is GBP · Price in CHF
39.55
-0.35 (-0.88%)
Jan 22, 2025, 5:33 PM BST
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 147 employees as of December 30, 2023. The number of employees increased by 6 or 4.26% compared to the previous year.
Employees
147
Change (1Y)
6
Growth (1Y)
4.26%
Revenue / Employee
841.17K GBP
Profits / Employee
-3.68K GBP
Market Cap
428.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Basilea Pharmaceutica AG News
- 5 months ago - Basilea Pharmaceutica AG (BPMUF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 10 months ago - US FDA approves Basilea Pharmaceutica's antibiotic - Reuters
- 1 year ago - Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio - GlobeNewsWire
- 1 year ago - Basilea Pharmaceutica AG (BPMUF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Basilea Pharmaceutica AG (BPMUF) Q4 2022 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Basilea announces repayment of 2022 convertible bonds - GlobeNewsWire
- 2 years ago - Basilea Pharmaceutica AG (BPMUF) CEO David Veitch on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha
- 2 years ago - Basilea Pharmaceutica (BSLN): Renewed Focus on Anti-Infectives - Accesswire